What Happened?
Oldwick, New Jersey-based Provention Bio Appointed Mick Nucum as Director, Information Technology
Date of management change: November 11, 2020
Oldwick, New Jersey-based Provention Bio Appointed Mick Nucum as Director, Information Technology
Provention Bio, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases. -We seek technologies or targets designed to predict, preempt or intervene before immune disease begins, re-appears or progresses. -We are creating a new biopharmaceutical category for autoimmunity. We leverage a transformational drug development strategy that sources, repositions and advances candidates that: -Target the interception or prevention of immune-mediated disease -Have been underdeveloped or deprioritized because of insufficient clinical trial efficacy or for strategic reasons -Have demonstrated proof-of-mechanism by preventing or intercepting immunopathologic pathways We believe that our deep understanding of immune-mediated pathophysiology, experience in translational medicine, and expertise in the design of rapid go/no-go clinical trials enables us to identify and evaluate potential therapeutic candidates for acquisition or in-licensing.
Mick Nucum is Director, Information Technology at Provention Bio. Previously, Mick held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Brizendine Michael, Eaton Wayne, Levin Eric, Louie Cory, Calabio Jean-Paul, Ward Tabice, Walsh Kevin, Borkowski Ellen, Fischer Phil, Brubaker Mark, Hakhinian Mushegh
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.